Cargando…

Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018

BACKGROUND: Prostate cancer is the most commonly diagnosed cancer in men. Radiotherapy represents one major treatment option in different therapeutic settings. As patients increasingly rely on internet-based medical information, we examined the quality of information on radiotherapy and prostate can...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, S., Fahlbusch, F. B., Käsmann, L., Rades, D., Vordermark, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537434/
https://www.ncbi.nlm.nih.gov/pubmed/31138209
http://dx.doi.org/10.1186/s12894-019-0474-4
_version_ 1783422011203125248
author Janssen, S.
Fahlbusch, F. B.
Käsmann, L.
Rades, D.
Vordermark, D.
author_facet Janssen, S.
Fahlbusch, F. B.
Käsmann, L.
Rades, D.
Vordermark, D.
author_sort Janssen, S.
collection PubMed
description BACKGROUND: Prostate cancer is the most commonly diagnosed cancer in men. Radiotherapy represents one major treatment option in different therapeutic settings. As patients increasingly rely on internet-based medical information, we examined the quality of information on radiotherapy and prostate cancer in websites used by laypersons. METHODS: An Internet search from a patients` perspective was carried out using different search engines (Google, Yahoo and Bing, search terms: “prostate cancer” and “radiotherapy”). The quality of search results was analyzed with regard to the DISCERN score, HON code certification, the JAMA criteria and the ALEXA traffic rank. RESULTS: In general, websites were of good quality. The highest quality was found for websites operated by charity organizations. No significant differences in results obtained via the above-mentioned tools were seen for the examined search engines, but Google revealed the most stable search results in terms of temporal changes. CONCLUSION: Patients with prostate cancer can sufficiently inform themselves on general treatment options including radiotherapy on websites directed at laypersons. However, no simple strategy could identify high quality websites in general. For treating physicians, it is important to support patients in interpreting and ranking the vast quantity of information. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12894-019-0474-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6537434
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65374342019-05-30 Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018 Janssen, S. Fahlbusch, F. B. Käsmann, L. Rades, D. Vordermark, D. BMC Urol Research Article BACKGROUND: Prostate cancer is the most commonly diagnosed cancer in men. Radiotherapy represents one major treatment option in different therapeutic settings. As patients increasingly rely on internet-based medical information, we examined the quality of information on radiotherapy and prostate cancer in websites used by laypersons. METHODS: An Internet search from a patients` perspective was carried out using different search engines (Google, Yahoo and Bing, search terms: “prostate cancer” and “radiotherapy”). The quality of search results was analyzed with regard to the DISCERN score, HON code certification, the JAMA criteria and the ALEXA traffic rank. RESULTS: In general, websites were of good quality. The highest quality was found for websites operated by charity organizations. No significant differences in results obtained via the above-mentioned tools were seen for the examined search engines, but Google revealed the most stable search results in terms of temporal changes. CONCLUSION: Patients with prostate cancer can sufficiently inform themselves on general treatment options including radiotherapy on websites directed at laypersons. However, no simple strategy could identify high quality websites in general. For treating physicians, it is important to support patients in interpreting and ranking the vast quantity of information. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12894-019-0474-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-28 /pmc/articles/PMC6537434/ /pubmed/31138209 http://dx.doi.org/10.1186/s12894-019-0474-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Janssen, S.
Fahlbusch, F. B.
Käsmann, L.
Rades, D.
Vordermark, D.
Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018
title Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018
title_full Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018
title_fullStr Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018
title_full_unstemmed Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018
title_short Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018
title_sort radiotherapy for prostate cancer: discern quality assessment of patient-oriented websites in 2018
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537434/
https://www.ncbi.nlm.nih.gov/pubmed/31138209
http://dx.doi.org/10.1186/s12894-019-0474-4
work_keys_str_mv AT janssens radiotherapyforprostatecancerdiscernqualityassessmentofpatientorientedwebsitesin2018
AT fahlbuschfb radiotherapyforprostatecancerdiscernqualityassessmentofpatientorientedwebsitesin2018
AT kasmannl radiotherapyforprostatecancerdiscernqualityassessmentofpatientorientedwebsitesin2018
AT radesd radiotherapyforprostatecancerdiscernqualityassessmentofpatientorientedwebsitesin2018
AT vordermarkd radiotherapyforprostatecancerdiscernqualityassessmentofpatientorientedwebsitesin2018